BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33897764)

  • 1. G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
    Sepúlveda N; Grignard L; Curry J; Mahey L; Bastiaens GJH; Tiono AB; Okebe J; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Lanke K; Sirima SB; Dicko A; d'Alessandro U; Clark TG; Campino S; Chen I; Eziefula AC; Gosling R; Bousema T; Drakeley C
    Front Genet; 2021; 12():645688. PubMed ID: 33897764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
    Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
    Graves PM; Choi L; Gelband H; Garner P
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
    Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
    Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
    van Beek SW; Svensson EM; Tiono AB; Okebe J; D'Alessandro U; Gonçalves BP; Bousema T; Drakeley C; Ter Heine R
    Parasit Vectors; 2021 Oct; 14(1):524. PubMed ID: 34627346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on hemoglobin levels in Ethiopia: a longitudinal cohort study.
    Habtamu K; Getachew H; Abossie A; Demissew A; Tsegaye A; Degefa T; Wang X; Lee MC; Zhou G; Kibret S; King CL; Kazura JW; Petros B; Yewhalaw D; Yan G
    Res Sq; 2024 Mar; ():. PubMed ID: 38559068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
    Bastiaens GJH; Tiono AB; Okebe J; Pett HE; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Bradley J; Lanke KHW; Niemi M; Sirima SB; d'Alessandro U; Bousema T; Drakeley C
    PLoS One; 2018; 13(1):e0190272. PubMed ID: 29324864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
    Recht J; Ashley EA; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pett H; Bradley J; Okebe J; Dicko A; Tiono AB; Gonçalves BP; Stone W; Chen I; Lanke K; Neuvonen M; Mustaniemi AL; Eziefula AC; Gosling R; D'Alessandro U; Drakeley C; Niemi M; Bousema T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Nucleotide Polymorphisms in Glucose-6-Phosphate Dehydrogenase and their Relevance for the Deployment of Primaquine as a Radical Cure for Malaria.
    Nain M; Gill J; Mohan M; Sharma A
    Am J Trop Med Hyg; 2023 Mar; 108(3):470-476. PubMed ID: 36746659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
    Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
    Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.
    Chen I; Diawara H; Mahamar A; Sanogo K; Keita S; Kone D; Diarra K; Djimde M; Keita M; Brown J; Roh ME; Hwang J; Pett H; Murphy M; Niemi M; Greenhouse B; Bousema T; Gosling R; Dicko A
    J Infect Dis; 2018 Mar; 217(8):1298-1308. PubMed ID: 29342267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.